211 related articles for article (PubMed ID: 31781300)
1. Determination of
Uloza V; Tamauskaite T; Vilkeviciute A; Pasvenskaite A; Liutkevicius V; Liutkeviciene R
Dis Markers; 2019; 2019():3907232. PubMed ID: 31781300
[TBL] [Abstract][Full Text] [Related]
2. Does
Gedvilaite G; Vilkeviciute A; Kriauciuniene L; Asmoniene V; Liutkeviciene R
Ophthalmic Genet; 2019 Jun; 40(3):219-226. PubMed ID: 31199170
[No Abstract] [Full Text] [Related]
3. Association of
Glebauskiene B; Vilkeviciute A; Liutkeviciene R; Jakstiene S; Kriauciuniene L; Zemaitiene R; Zaliuniene D
Oncol Lett; 2017 May; 13(5):3087-3099. PubMed ID: 28521414
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, LIPC rs10468017, rs493258 and LPL rs12678919 genotypes and haplotype evaluation in patients with age-related macular degeneration.
Liutkeviciene R; Vilkeviciute A; Kriauciuniene L; Deltuva VP
Gene; 2019 Feb; 686():8-15. PubMed ID: 30399423
[TBL] [Abstract][Full Text] [Related]
5. Association of SIRT1 single gene nucleotide polymorphisms and serum SIRT1 levels with laryngeal squamous cell carcinoma patient survival rate.
Vaiciulis P; Liutkeviciene R; Liutkevicius V; Vilkeviciute A; Gedvilaite G; Uloza V
Cancer Biomark; 2022; 34(2):175-188. PubMed ID: 34719479
[TBL] [Abstract][Full Text] [Related]
6. The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis.
Shao Y; Shao X; He J; Cai Y; Zhao J; Chen F; Tao H; Yin Z; Tan X; He Y; Lin Y; Li K; Cui L
Clin Genet; 2017 Apr; 91(4):564-575. PubMed ID: 27172264
[TBL] [Abstract][Full Text] [Related]
7. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
Chen Y; Shi C; Guo Q
World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
[TBL] [Abstract][Full Text] [Related]
8. Tendencies of FGFR2 rs2981582 polymorphism in patients with oral cancer.
Liutkevicius V; Tamauskaite T; Vilkeviciute A; Liutkeviciene R; Smalinskaite R; Giedraitiene A; Smalinskiene A; Uloza V
Stomatologija; 2020; 22(1):3-8. PubMed ID: 32706340
[TBL] [Abstract][Full Text] [Related]
9. Association of
Kolonaite G; Vilkeviciute A; Kriauciuniene L; Gedvilaite G; Liutkeviciene R
Ophthalmic Genet; 2021 Dec; 42(6):685-690. PubMed ID: 34338585
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma.
Al-Khaykanee AM; Abdel-Rahman AA; Essa A; Gadallah AA; Ali BH; Al-Aqar AA; Badr EAE; Shehab-Eldeen S
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101636. PubMed ID: 33740609
[TBL] [Abstract][Full Text] [Related]
11. Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians.
Rizk SM; Shahin NN; Shaker OG
PLoS One; 2016; 11(3):e0151901. PubMed ID: 26999517
[TBL] [Abstract][Full Text] [Related]
12. Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival.
Hung SC; Wang SS; Li JR; Chen CS; Lin CY; Chang LW; Chiu KY; Cheng CL; Ou YC; Yang SF
Urol Oncol; 2019 Sep; 37(9):573.e9-573.e17. PubMed ID: 30824390
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma.
Zhou J; Yang Y; Zhang D; Zhou L; Tao L; Lu LM
PLoS One; 2017; 12(2):e0171116. PubMed ID: 28225775
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.
Zhao XD; Zhang W; Liang HJ; Ji WY
PLoS One; 2013; 8(2):e56395. PubMed ID: 23437123
[TBL] [Abstract][Full Text] [Related]
15. Genetic predisposition of six well-defined polymorphisms in HMGB1/RAGE pathway to breast cancer in a large Han Chinese population.
Yue L; Zhang Q; He L; Zhang M; Dong J; Zhao D; Ma H; Pan H; Zheng L
J Cell Mol Med; 2016 Oct; 20(10):1966-73. PubMed ID: 27241711
[TBL] [Abstract][Full Text] [Related]
16. The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration.
Banevicius M; Vilkeviciute A; Kriauciuniene L; Liutkeviciene R; Deltuva VP
Med Sci Monit; 2018 Jan; 24():190-199. PubMed ID: 29317590
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of Stat3 and Cyclin D1 expression in laryngeal squamous cell carcinoma].
Wang L; Duan X; Tang X; Shao Y; Zhao R; Qian X; Gao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 25(21):966-9. PubMed ID: 22260073
[TBL] [Abstract][Full Text] [Related]
18. RAGE gene polymorphism and environmental factor in the risk of oral cancer.
Su S; Chien M; Lin C; Chen M; Yang S
J Dent Res; 2015 Mar; 94(3):403-11. PubMed ID: 25582438
[TBL] [Abstract][Full Text] [Related]
19. Association of RAGE rs1800625 Polymorphism and Cancer Risk: A Meta-Analysis of 18 Case-Control Studies.
Xu Y; Lu Z; Shen N; Wang X
Med Sci Monit; 2019 Sep; 25():7026-7034. PubMed ID: 31534114
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
Mehta R; Shaw G; Masschelin P; Felix S; Otgonsuren M; Baranova A; Goodman Z; Younossi Z
PLoS One; 2018; 13(6):e0199294. PubMed ID: 29928018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
